Global Mumps Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
LPI (LP Information)' newest research report, the “Mumps Vaccine Industry Forecast” looks at past sales and reviews total world Mumps Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mumps Vaccine sales for 2023 through 2029. With Mumps Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mumps Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Mumps Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mumps Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mumps Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mumps Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mumps Vaccine.
The global Mumps Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mumps Vaccine players cover MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mumps Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Mumps Vaccine market?
What factors are driving Mumps Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mumps Vaccine market opportunities vary by end market size?
How does Mumps Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
LPI (LP Information)' newest research report, the “Mumps Vaccine Industry Forecast” looks at past sales and reviews total world Mumps Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mumps Vaccine sales for 2023 through 2029. With Mumps Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mumps Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Mumps Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mumps Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mumps Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mumps Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mumps Vaccine.
The global Mumps Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mumps Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mumps Vaccine players cover MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mumps Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Child
- Adult
- Hospitals Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MedImmune
- Johnson & Johnson
- Merck & Co., Inc.
- Sanofi
- Serum Institute of India
- Bavarian Nordic
- Astellas Pharma India
- CSL Limited
- Emergent BioSolutions
- GlaxoSmithKline
- Panacea Biotec, Ltd.
- Biological E Limited
- Bharat Biotech Ltd.
- Novavax, Inc.
- Novartis
- Sinovac Biotech, Ltd.
- Incepta Vaccine Limited
- Valneva SE
- VBI Vaccines
- PT Bio Farma
What is the 10-year outlook for the global Mumps Vaccine market?
What factors are driving Mumps Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mumps Vaccine market opportunities vary by end market size?
How does Mumps Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mumps Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mumps Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mumps Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Mumps Vaccine Segment by Type
2.2.1 Child
2.2.2 Adult
2.3 Mumps Vaccine Sales by Type
2.3.1 Global Mumps Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Mumps Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mumps Vaccine Sale Price by Type (2018-2023)
2.4 Mumps Vaccine Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Mumps Vaccine Sales by Application
2.5.1 Global Mumps Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Mumps Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mumps Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MUMPS VACCINE BY COMPANY
3.1 Global Mumps Vaccine Breakdown Data by Company
3.1.1 Global Mumps Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Mumps Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Mumps Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Mumps Vaccine Revenue by Company (2018-2023)
3.2.2 Global Mumps Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Mumps Vaccine Sale Price by Company
3.4 Key Manufacturers Mumps Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mumps Vaccine Product Location Distribution
3.4.2 Players Mumps Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUMPS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Mumps Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mumps Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mumps Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mumps Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Mumps Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mumps Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mumps Vaccine Sales Growth
4.4 APAC Mumps Vaccine Sales Growth
4.5 Europe Mumps Vaccine Sales Growth
4.6 Middle East & Africa Mumps Vaccine Sales Growth
5 AMERICAS
5.1 Americas Mumps Vaccine Sales by Country
5.1.1 Americas Mumps Vaccine Sales by Country (2018-2023)
5.1.2 Americas Mumps Vaccine Revenue by Country (2018-2023)
5.2 Americas Mumps Vaccine Sales by Type
5.3 Americas Mumps Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mumps Vaccine Sales by Region
6.1.1 APAC Mumps Vaccine Sales by Region (2018-2023)
6.1.2 APAC Mumps Vaccine Revenue by Region (2018-2023)
6.2 APAC Mumps Vaccine Sales by Type
6.3 APAC Mumps Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mumps Vaccine by Country
7.1.1 Europe Mumps Vaccine Sales by Country (2018-2023)
7.1.2 Europe Mumps Vaccine Revenue by Country (2018-2023)
7.2 Europe Mumps Vaccine Sales by Type
7.3 Europe Mumps Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mumps Vaccine by Country
8.1.1 Middle East & Africa Mumps Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mumps Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mumps Vaccine Sales by Type
8.3 Middle East & Africa Mumps Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Vaccine
10.3 Manufacturing Process Analysis of Mumps Vaccine
10.4 Industry Chain Structure of Mumps Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mumps Vaccine Distributors
11.3 Mumps Vaccine Customer
12 WORLD FORECAST REVIEW FOR MUMPS VACCINE BY GEOGRAPHIC REGION
12.1 Global Mumps Vaccine Market Size Forecast by Region
12.1.1 Global Mumps Vaccine Forecast by Region (2024-2029)
12.1.2 Global Mumps Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mumps Vaccine Forecast by Type
12.7 Global Mumps Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MedImmune
13.1.1 MedImmune Company Information
13.1.2 MedImmune Mumps Vaccine Product Portfolios and Specifications
13.1.3 MedImmune Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MedImmune Main Business Overview
13.1.5 MedImmune Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Mumps Vaccine Product Portfolios and Specifications
13.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck & Co., Inc.
13.3.1 Merck & Co., Inc. Company Information
13.3.2 Merck & Co., Inc. Mumps Vaccine Product Portfolios and Specifications
13.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co., Inc. Main Business Overview
13.3.5 Merck & Co., Inc. Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Mumps Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Mumps Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Bavarian Nordic
13.6.1 Bavarian Nordic Company Information
13.6.2 Bavarian Nordic Mumps Vaccine Product Portfolios and Specifications
13.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bavarian Nordic Main Business Overview
13.6.5 Bavarian Nordic Latest Developments
13.7 Astellas Pharma India
13.7.1 Astellas Pharma India Company Information
13.7.2 Astellas Pharma India Mumps Vaccine Product Portfolios and Specifications
13.7.3 Astellas Pharma India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Astellas Pharma India Main Business Overview
13.7.5 Astellas Pharma India Latest Developments
13.8 CSL Limited
13.8.1 CSL Limited Company Information
13.8.2 CSL Limited Mumps Vaccine Product Portfolios and Specifications
13.8.3 CSL Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CSL Limited Main Business Overview
13.8.5 CSL Limited Latest Developments
13.9 Emergent BioSolutions
13.9.1 Emergent BioSolutions Company Information
13.9.2 Emergent BioSolutions Mumps Vaccine Product Portfolios and Specifications
13.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Emergent BioSolutions Main Business Overview
13.9.5 Emergent BioSolutions Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Mumps Vaccine Product Portfolios and Specifications
13.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Panacea Biotec, Ltd.
13.11.1 Panacea Biotec, Ltd. Company Information
13.11.2 Panacea Biotec, Ltd. Mumps Vaccine Product Portfolios and Specifications
13.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Panacea Biotec, Ltd. Main Business Overview
13.11.5 Panacea Biotec, Ltd. Latest Developments
13.12 Biological E Limited
13.12.1 Biological E Limited Company Information
13.12.2 Biological E Limited Mumps Vaccine Product Portfolios and Specifications
13.12.3 Biological E Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biological E Limited Main Business Overview
13.12.5 Biological E Limited Latest Developments
13.13 Bharat Biotech Ltd.
13.13.1 Bharat Biotech Ltd. Company Information
13.13.2 Bharat Biotech Ltd. Mumps Vaccine Product Portfolios and Specifications
13.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bharat Biotech Ltd. Main Business Overview
13.13.5 Bharat Biotech Ltd. Latest Developments
13.14 Novavax, Inc.
13.14.1 Novavax, Inc. Company Information
13.14.2 Novavax, Inc. Mumps Vaccine Product Portfolios and Specifications
13.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Novavax, Inc. Main Business Overview
13.14.5 Novavax, Inc. Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Mumps Vaccine Product Portfolios and Specifications
13.15.3 Novartis Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Sinovac Biotech, Ltd.
13.16.1 Sinovac Biotech, Ltd. Company Information
13.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolios and Specifications
13.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sinovac Biotech, Ltd. Main Business Overview
13.16.5 Sinovac Biotech, Ltd. Latest Developments
13.17 Incepta Vaccine Limited
13.17.1 Incepta Vaccine Limited Company Information
13.17.2 Incepta Vaccine Limited Mumps Vaccine Product Portfolios and Specifications
13.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Incepta Vaccine Limited Main Business Overview
13.17.5 Incepta Vaccine Limited Latest Developments
13.18 Valneva SE
13.18.1 Valneva SE Company Information
13.18.2 Valneva SE Mumps Vaccine Product Portfolios and Specifications
13.18.3 Valneva SE Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Valneva SE Main Business Overview
13.18.5 Valneva SE Latest Developments
13.19 VBI Vaccines
13.19.1 VBI Vaccines Company Information
13.19.2 VBI Vaccines Mumps Vaccine Product Portfolios and Specifications
13.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 VBI Vaccines Main Business Overview
13.19.5 VBI Vaccines Latest Developments
13.20 PT Bio Farma
13.20.1 PT Bio Farma Company Information
13.20.2 PT Bio Farma Mumps Vaccine Product Portfolios and Specifications
13.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 PT Bio Farma Main Business Overview
13.20.5 PT Bio Farma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mumps Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mumps Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mumps Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Mumps Vaccine Segment by Type
2.2.1 Child
2.2.2 Adult
2.3 Mumps Vaccine Sales by Type
2.3.1 Global Mumps Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Mumps Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mumps Vaccine Sale Price by Type (2018-2023)
2.4 Mumps Vaccine Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Mumps Vaccine Sales by Application
2.5.1 Global Mumps Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Mumps Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mumps Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MUMPS VACCINE BY COMPANY
3.1 Global Mumps Vaccine Breakdown Data by Company
3.1.1 Global Mumps Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Mumps Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Mumps Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Mumps Vaccine Revenue by Company (2018-2023)
3.2.2 Global Mumps Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Mumps Vaccine Sale Price by Company
3.4 Key Manufacturers Mumps Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mumps Vaccine Product Location Distribution
3.4.2 Players Mumps Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MUMPS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Mumps Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mumps Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mumps Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mumps Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Mumps Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mumps Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mumps Vaccine Sales Growth
4.4 APAC Mumps Vaccine Sales Growth
4.5 Europe Mumps Vaccine Sales Growth
4.6 Middle East & Africa Mumps Vaccine Sales Growth
5 AMERICAS
5.1 Americas Mumps Vaccine Sales by Country
5.1.1 Americas Mumps Vaccine Sales by Country (2018-2023)
5.1.2 Americas Mumps Vaccine Revenue by Country (2018-2023)
5.2 Americas Mumps Vaccine Sales by Type
5.3 Americas Mumps Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mumps Vaccine Sales by Region
6.1.1 APAC Mumps Vaccine Sales by Region (2018-2023)
6.1.2 APAC Mumps Vaccine Revenue by Region (2018-2023)
6.2 APAC Mumps Vaccine Sales by Type
6.3 APAC Mumps Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mumps Vaccine by Country
7.1.1 Europe Mumps Vaccine Sales by Country (2018-2023)
7.1.2 Europe Mumps Vaccine Revenue by Country (2018-2023)
7.2 Europe Mumps Vaccine Sales by Type
7.3 Europe Mumps Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mumps Vaccine by Country
8.1.1 Middle East & Africa Mumps Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mumps Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mumps Vaccine Sales by Type
8.3 Middle East & Africa Mumps Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Vaccine
10.3 Manufacturing Process Analysis of Mumps Vaccine
10.4 Industry Chain Structure of Mumps Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mumps Vaccine Distributors
11.3 Mumps Vaccine Customer
12 WORLD FORECAST REVIEW FOR MUMPS VACCINE BY GEOGRAPHIC REGION
12.1 Global Mumps Vaccine Market Size Forecast by Region
12.1.1 Global Mumps Vaccine Forecast by Region (2024-2029)
12.1.2 Global Mumps Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mumps Vaccine Forecast by Type
12.7 Global Mumps Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MedImmune
13.1.1 MedImmune Company Information
13.1.2 MedImmune Mumps Vaccine Product Portfolios and Specifications
13.1.3 MedImmune Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MedImmune Main Business Overview
13.1.5 MedImmune Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Mumps Vaccine Product Portfolios and Specifications
13.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck & Co., Inc.
13.3.1 Merck & Co., Inc. Company Information
13.3.2 Merck & Co., Inc. Mumps Vaccine Product Portfolios and Specifications
13.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co., Inc. Main Business Overview
13.3.5 Merck & Co., Inc. Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Mumps Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Mumps Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Bavarian Nordic
13.6.1 Bavarian Nordic Company Information
13.6.2 Bavarian Nordic Mumps Vaccine Product Portfolios and Specifications
13.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bavarian Nordic Main Business Overview
13.6.5 Bavarian Nordic Latest Developments
13.7 Astellas Pharma India
13.7.1 Astellas Pharma India Company Information
13.7.2 Astellas Pharma India Mumps Vaccine Product Portfolios and Specifications
13.7.3 Astellas Pharma India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Astellas Pharma India Main Business Overview
13.7.5 Astellas Pharma India Latest Developments
13.8 CSL Limited
13.8.1 CSL Limited Company Information
13.8.2 CSL Limited Mumps Vaccine Product Portfolios and Specifications
13.8.3 CSL Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CSL Limited Main Business Overview
13.8.5 CSL Limited Latest Developments
13.9 Emergent BioSolutions
13.9.1 Emergent BioSolutions Company Information
13.9.2 Emergent BioSolutions Mumps Vaccine Product Portfolios and Specifications
13.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Emergent BioSolutions Main Business Overview
13.9.5 Emergent BioSolutions Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Mumps Vaccine Product Portfolios and Specifications
13.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Panacea Biotec, Ltd.
13.11.1 Panacea Biotec, Ltd. Company Information
13.11.2 Panacea Biotec, Ltd. Mumps Vaccine Product Portfolios and Specifications
13.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Panacea Biotec, Ltd. Main Business Overview
13.11.5 Panacea Biotec, Ltd. Latest Developments
13.12 Biological E Limited
13.12.1 Biological E Limited Company Information
13.12.2 Biological E Limited Mumps Vaccine Product Portfolios and Specifications
13.12.3 Biological E Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biological E Limited Main Business Overview
13.12.5 Biological E Limited Latest Developments
13.13 Bharat Biotech Ltd.
13.13.1 Bharat Biotech Ltd. Company Information
13.13.2 Bharat Biotech Ltd. Mumps Vaccine Product Portfolios and Specifications
13.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bharat Biotech Ltd. Main Business Overview
13.13.5 Bharat Biotech Ltd. Latest Developments
13.14 Novavax, Inc.
13.14.1 Novavax, Inc. Company Information
13.14.2 Novavax, Inc. Mumps Vaccine Product Portfolios and Specifications
13.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Novavax, Inc. Main Business Overview
13.14.5 Novavax, Inc. Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Mumps Vaccine Product Portfolios and Specifications
13.15.3 Novartis Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Sinovac Biotech, Ltd.
13.16.1 Sinovac Biotech, Ltd. Company Information
13.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolios and Specifications
13.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sinovac Biotech, Ltd. Main Business Overview
13.16.5 Sinovac Biotech, Ltd. Latest Developments
13.17 Incepta Vaccine Limited
13.17.1 Incepta Vaccine Limited Company Information
13.17.2 Incepta Vaccine Limited Mumps Vaccine Product Portfolios and Specifications
13.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Incepta Vaccine Limited Main Business Overview
13.17.5 Incepta Vaccine Limited Latest Developments
13.18 Valneva SE
13.18.1 Valneva SE Company Information
13.18.2 Valneva SE Mumps Vaccine Product Portfolios and Specifications
13.18.3 Valneva SE Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Valneva SE Main Business Overview
13.18.5 Valneva SE Latest Developments
13.19 VBI Vaccines
13.19.1 VBI Vaccines Company Information
13.19.2 VBI Vaccines Mumps Vaccine Product Portfolios and Specifications
13.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 VBI Vaccines Main Business Overview
13.19.5 VBI Vaccines Latest Developments
13.20 PT Bio Farma
13.20.1 PT Bio Farma Company Information
13.20.2 PT Bio Farma Mumps Vaccine Product Portfolios and Specifications
13.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 PT Bio Farma Main Business Overview
13.20.5 PT Bio Farma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mumps Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mumps Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Child
Table 4. Major Players of Adult
Table 5. Global Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mumps Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Mumps Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mumps Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Mumps Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mumps Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Mumps Vaccine Revenue by Application (2018-2023)
Table 13. Global Mumps Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Mumps Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mumps Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mumps Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Mumps Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mumps Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Mumps Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mumps Vaccine Producing Area Distribution and Sales Area
Table 21. Players Mumps Vaccine Products Offered
Table 22. Mumps Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mumps Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mumps Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mumps Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mumps Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mumps Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mumps Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mumps Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mumps Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mumps Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mumps Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Mumps Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mumps Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mumps Vaccine
Table 58. Key Market Challenges & Risks of Mumps Vaccine
Table 59. Key Industry Trends of Mumps Vaccine
Table 60. Mumps Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mumps Vaccine Distributors List
Table 63. Mumps Vaccine Customer List
Table 64. Global Mumps Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mumps Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mumps Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mumps Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mumps Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mumps Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mumps Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mumps Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MedImmune Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. MedImmune Mumps Vaccine Product Portfolios and Specifications
Table 80. MedImmune Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MedImmune Main Business
Table 82. MedImmune Latest Developments
Table 83. Johnson & Johnson Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Mumps Vaccine Product Portfolios and Specifications
Table 85. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Merck & Co., Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co., Inc. Mumps Vaccine Product Portfolios and Specifications
Table 90. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck & Co., Inc. Main Business
Table 92. Merck & Co., Inc. Latest Developments
Table 93. Sanofi Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Mumps Vaccine Product Portfolios and Specifications
Table 95. Sanofi Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Serum Institute of India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Mumps Vaccine Product Portfolios and Specifications
Table 100. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. Bavarian Nordic Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Bavarian Nordic Mumps Vaccine Product Portfolios and Specifications
Table 105. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bavarian Nordic Main Business
Table 107. Bavarian Nordic Latest Developments
Table 108. Astellas Pharma India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Astellas Pharma India Mumps Vaccine Product Portfolios and Specifications
Table 110. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Astellas Pharma India Main Business
Table 112. Astellas Pharma India Latest Developments
Table 113. CSL Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. CSL Limited Mumps Vaccine Product Portfolios and Specifications
Table 115. CSL Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. CSL Limited Main Business
Table 117. CSL Limited Latest Developments
Table 118. Emergent BioSolutions Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Emergent BioSolutions Mumps Vaccine Product Portfolios and Specifications
Table 120. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Emergent BioSolutions Main Business
Table 122. Emergent BioSolutions Latest Developments
Table 123. GlaxoSmithKline Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. GlaxoSmithKline Mumps Vaccine Product Portfolios and Specifications
Table 125. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. GlaxoSmithKline Main Business
Table 127. GlaxoSmithKline Latest Developments
Table 128. Panacea Biotec, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Panacea Biotec, Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 130. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Panacea Biotec, Ltd. Main Business
Table 132. Panacea Biotec, Ltd. Latest Developments
Table 133. Biological E Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Biological E Limited Mumps Vaccine Product Portfolios and Specifications
Table 135. Biological E Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Biological E Limited Main Business
Table 137. Biological E Limited Latest Developments
Table 138. Bharat Biotech Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Bharat Biotech Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 140. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Bharat Biotech Ltd. Main Business
Table 142. Bharat Biotech Ltd. Latest Developments
Table 143. Novavax, Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Novavax, Inc. Mumps Vaccine Product Portfolios and Specifications
Table 145. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Novavax, Inc. Main Business
Table 147. Novavax, Inc. Latest Developments
Table 148. Novartis Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Novartis Mumps Vaccine Product Portfolios and Specifications
Table 150. Novartis Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Novartis Main Business
Table 152. Novartis Latest Developments
Table 153. Sinovac Biotech, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 155. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Sinovac Biotech, Ltd. Main Business
Table 157. Sinovac Biotech, Ltd. Latest Developments
Table 158. Incepta Vaccine Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Incepta Vaccine Limited Mumps Vaccine Product Portfolios and Specifications
Table 160. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Incepta Vaccine Limited Main Business
Table 162. Incepta Vaccine Limited Latest Developments
Table 163. Valneva SE Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Valneva SE Mumps Vaccine Product Portfolios and Specifications
Table 165. Valneva SE Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Valneva SE Main Business
Table 167. Valneva SE Latest Developments
Table 168. VBI Vaccines Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 169. VBI Vaccines Mumps Vaccine Product Portfolios and Specifications
Table 170. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. VBI Vaccines Main Business
Table 172. VBI Vaccines Latest Developments
Table 173. PT Bio Farma Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 174. PT Bio Farma Mumps Vaccine Product Portfolios and Specifications
Table 175. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. PT Bio Farma Main Business
Table 177. PT Bio Farma Latest Developments
Table 1. Mumps Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mumps Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Child
Table 4. Major Players of Adult
Table 5. Global Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mumps Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Mumps Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mumps Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Mumps Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mumps Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Mumps Vaccine Revenue by Application (2018-2023)
Table 13. Global Mumps Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Mumps Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mumps Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mumps Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Mumps Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mumps Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Mumps Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mumps Vaccine Producing Area Distribution and Sales Area
Table 21. Players Mumps Vaccine Products Offered
Table 22. Mumps Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mumps Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mumps Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mumps Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mumps Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mumps Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mumps Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mumps Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mumps Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mumps Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mumps Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Mumps Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mumps Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mumps Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mumps Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mumps Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mumps Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mumps Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mumps Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mumps Vaccine
Table 58. Key Market Challenges & Risks of Mumps Vaccine
Table 59. Key Industry Trends of Mumps Vaccine
Table 60. Mumps Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mumps Vaccine Distributors List
Table 63. Mumps Vaccine Customer List
Table 64. Global Mumps Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mumps Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mumps Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mumps Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mumps Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mumps Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mumps Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mumps Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mumps Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mumps Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MedImmune Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. MedImmune Mumps Vaccine Product Portfolios and Specifications
Table 80. MedImmune Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MedImmune Main Business
Table 82. MedImmune Latest Developments
Table 83. Johnson & Johnson Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Mumps Vaccine Product Portfolios and Specifications
Table 85. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Merck & Co., Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co., Inc. Mumps Vaccine Product Portfolios and Specifications
Table 90. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck & Co., Inc. Main Business
Table 92. Merck & Co., Inc. Latest Developments
Table 93. Sanofi Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Mumps Vaccine Product Portfolios and Specifications
Table 95. Sanofi Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Serum Institute of India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Mumps Vaccine Product Portfolios and Specifications
Table 100. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. Bavarian Nordic Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Bavarian Nordic Mumps Vaccine Product Portfolios and Specifications
Table 105. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bavarian Nordic Main Business
Table 107. Bavarian Nordic Latest Developments
Table 108. Astellas Pharma India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Astellas Pharma India Mumps Vaccine Product Portfolios and Specifications
Table 110. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Astellas Pharma India Main Business
Table 112. Astellas Pharma India Latest Developments
Table 113. CSL Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. CSL Limited Mumps Vaccine Product Portfolios and Specifications
Table 115. CSL Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. CSL Limited Main Business
Table 117. CSL Limited Latest Developments
Table 118. Emergent BioSolutions Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Emergent BioSolutions Mumps Vaccine Product Portfolios and Specifications
Table 120. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Emergent BioSolutions Main Business
Table 122. Emergent BioSolutions Latest Developments
Table 123. GlaxoSmithKline Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. GlaxoSmithKline Mumps Vaccine Product Portfolios and Specifications
Table 125. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. GlaxoSmithKline Main Business
Table 127. GlaxoSmithKline Latest Developments
Table 128. Panacea Biotec, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Panacea Biotec, Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 130. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Panacea Biotec, Ltd. Main Business
Table 132. Panacea Biotec, Ltd. Latest Developments
Table 133. Biological E Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Biological E Limited Mumps Vaccine Product Portfolios and Specifications
Table 135. Biological E Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Biological E Limited Main Business
Table 137. Biological E Limited Latest Developments
Table 138. Bharat Biotech Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Bharat Biotech Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 140. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Bharat Biotech Ltd. Main Business
Table 142. Bharat Biotech Ltd. Latest Developments
Table 143. Novavax, Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Novavax, Inc. Mumps Vaccine Product Portfolios and Specifications
Table 145. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Novavax, Inc. Main Business
Table 147. Novavax, Inc. Latest Developments
Table 148. Novartis Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Novartis Mumps Vaccine Product Portfolios and Specifications
Table 150. Novartis Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Novartis Main Business
Table 152. Novartis Latest Developments
Table 153. Sinovac Biotech, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolios and Specifications
Table 155. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Sinovac Biotech, Ltd. Main Business
Table 157. Sinovac Biotech, Ltd. Latest Developments
Table 158. Incepta Vaccine Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Incepta Vaccine Limited Mumps Vaccine Product Portfolios and Specifications
Table 160. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Incepta Vaccine Limited Main Business
Table 162. Incepta Vaccine Limited Latest Developments
Table 163. Valneva SE Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Valneva SE Mumps Vaccine Product Portfolios and Specifications
Table 165. Valneva SE Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Valneva SE Main Business
Table 167. Valneva SE Latest Developments
Table 168. VBI Vaccines Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 169. VBI Vaccines Mumps Vaccine Product Portfolios and Specifications
Table 170. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. VBI Vaccines Main Business
Table 172. VBI Vaccines Latest Developments
Table 173. PT Bio Farma Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 174. PT Bio Farma Mumps Vaccine Product Portfolios and Specifications
Table 175. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. PT Bio Farma Main Business
Table 177. PT Bio Farma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mumps Vaccine
Figure 2. Mumps Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mumps Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mumps Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Child
Figure 10. Product Picture of Adult
Figure 11. Global Mumps Vaccine Sales Market Share by Type in 2022
Figure 12. Global Mumps Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Mumps Vaccine Consumed in Hospitals Pharmacies
Figure 14. Global Mumps Vaccine Market: Hospitals Pharmacies (2018-2023) & (K Units)
Figure 15. Mumps Vaccine Consumed in Retail Pharmacies
Figure 16. Global Mumps Vaccine Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Global Mumps Vaccine Sales Market Share by Application (2022)
Figure 18. Global Mumps Vaccine Revenue Market Share by Application in 2022
Figure 19. Mumps Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Mumps Vaccine Sales Market Share by Company in 2022
Figure 21. Mumps Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Mumps Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Mumps Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Mumps Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Mumps Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Mumps Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Mumps Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Mumps Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Mumps Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Mumps Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Mumps Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Mumps Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Mumps Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Mumps Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Mumps Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Mumps Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Mumps Vaccine
Figure 72. Industry Chain Structure of Mumps Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Mumps Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Mumps Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Mumps Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Mumps Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Mumps Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Mumps Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Mumps Vaccine
Figure 2. Mumps Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mumps Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mumps Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Child
Figure 10. Product Picture of Adult
Figure 11. Global Mumps Vaccine Sales Market Share by Type in 2022
Figure 12. Global Mumps Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Mumps Vaccine Consumed in Hospitals Pharmacies
Figure 14. Global Mumps Vaccine Market: Hospitals Pharmacies (2018-2023) & (K Units)
Figure 15. Mumps Vaccine Consumed in Retail Pharmacies
Figure 16. Global Mumps Vaccine Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Global Mumps Vaccine Sales Market Share by Application (2022)
Figure 18. Global Mumps Vaccine Revenue Market Share by Application in 2022
Figure 19. Mumps Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Mumps Vaccine Sales Market Share by Company in 2022
Figure 21. Mumps Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Mumps Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Mumps Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Mumps Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Mumps Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Mumps Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Mumps Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Mumps Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Mumps Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Mumps Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Mumps Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Mumps Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Mumps Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Mumps Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Mumps Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Mumps Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Mumps Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Mumps Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Mumps Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Mumps Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Mumps Vaccine
Figure 72. Industry Chain Structure of Mumps Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Mumps Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Mumps Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Mumps Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Mumps Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Mumps Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Mumps Vaccine Revenue Market Share Forecast by Application (2024-2029)
